Silvia Velasco

Dr. Silvia Velasco

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2022 in Nature
Verified
Journal Article
Closed access
PDF file
BPBruna Paulsen
Bruna Paulsen
SVSilvia Velasco
Silvia Velasco
AKAmanda J. Kedaigle
Amanda J. Kedaigle
MPMartina Pigoni
Martina Pigoni
GQGiorgia Quadrato
Giorgia Quadrato
PAPaola Arlotta
Paola Arlotta

19 March 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
AUAna Uzquiano
Ana Uzquiano
AKAmanda J. Kedaigle
Amanda J. Kedaigle
MPMartina Pigoni
Martina Pigoni
BPBruna Paulsen
Bruna Paulsen
XAXian Adiconis
Xian Adiconis
PAPaola Arlotta
Paola Arlotta
Realizing the full utility of brain organoids as experimental systems to study human cortical development requires understanding whether organoids replicate the cellular and molecular events of this complex process precisely, reproducibly, and with fidelity to the embryo. Here we present a comprehensive single-cell transcriptomic, epigenetic, and spatial atlas of human cortical organoid development, comprising over 610,000 cells, spanning initial generation of neural progenitors through production of differentiated neuronal and glial subtypes. We define the lineage relationships and longitudinal molecular trajectories of cortical cell types during development in organoids, and show that developmental processes of cellular diversification in organoids correlate closely to endogenous ones, irrespective of metabolic state. Using this data, we identify genes with predicted human-specific roles in lineage establishment, and discover a developmental origin for the transcriptional diversity of human callosal projection neurons, a population that has undergone dramatic expansion and diversification during human evolution. Our work provides a comprehensive, single-cell molecular map of human corticogenesis in vitro , identifying developmental trajectories and molecular mechanisms associated with human cellular diversification.

12 November 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
BPBruna Paulsen
Bruna Paulsen
SVSilvia Velasco
Silvia Velasco
AKAmanda J. Kedaigle
Amanda J. Kedaigle
MPMartina Pigoni
Martina Pigoni
GQGiorgia Quadrato
Giorgia Quadrato
PAPaola Arlotta
Paola Arlotta
Genetic risk for autism spectrum disorder (ASD) has been associated with hundreds of genes spanning a wide range of biological functions. The phenotypic alterations in the human brain resulting from mutations in ASD risk genes remain unclear, and the level at which these alterations converge on shared disease pathology is poorly understood. Here, we leveraged reproducible organoid models of the human cerebral cortex to identify cell type-specific developmental abnormalities associated with haploinsufficiency in three ASD risk genes, SUV420H1 ( KMT5B ), PTEN , and CHD8 . We performed comprehensive single-cell RNA-sequencing (scRNA-seq) of over 400,000 cells, and proteomic analysis on individual organoids sampled at different developmental stages to investigate phenotypic convergence among these genes. We find that within a defined period of early cortical development, each of the three mutations demonstrates accelerated development of cortical neurons. Notably, they do so by affecting different neuronal populations: excitatory deep layer ( SUV420H1 ) and callosal ( PTEN ) neurons, and inhibitory interneurons ( CHD8 ). This work shows that haploinsufficiency in ASD risk genes converge on early developmental defects in the generation of neurons of the cortical microcircuit.

6 June 2019 in Research Square
Verified
Preprint
Open access
SVSilvia Velasco
Silvia Velasco
BPBruna Paulsen
Bruna Paulsen
PAPaola Arlotta
Paola Arlotta
Human brain organoids hold an unprecedented opportunity to observe, perturb, and study the early stages of human cortical development. Several protocols to generate brain organoids have been described in recent years[1, 2]. However, incomplete characterization and lack of organoid-to-organoid reproducibility has limited their application as an experimental model[3]. Here we describe a detailed protocol for the generation of human dorsal forebrain organoids that show highly reproducible generation of the rich diversity of cell types present in the developing human cerebral cortex. This protocol is a modification of a previous method described by Kadoshima et al.[4]. We also include a detailed description of the protocol used to dissociate organoids into single cells for single-cell RNA-sequencing.

Verified
Journal Article
Open access
PDF file
RHRiley Hall
Riley Hall
VSVallari Sawant
Vallari Sawant
JGJinchao Gu
Jinchao Gu
TSTim Sikora
Tim Sikora
BRBen N Rollo
Ben N Rollo
NBNicole J Van Bergen
Nicole J Van Bergen
The TRAPP (TRAnsport Protein Particle) protein complex is a multi-subunit complex involved in vesicular transport between intracellular compartments. The TRAPP complex plays an important role in endoplasmic reticulum-to-Golgi and Golgi-to-plasma membrane transport, as well as autophagy. TRAPP complexes comprise a core complex, TRAPPI, and the association of peripheral protein subunits to make two complexes, known as TRAPPII and TRAPPIII, which act as Guanine Nucleotide Exchange Factors (GEFs) of Rab11 and Rab1, respectively. Rab1 and Rab11 are GTPases that mediate cargo selection, packaging, and delivery during pre- and post-Golgi transport in the secretory pathway. Rab1 is also required for the first step of macroautophagy, a cellular recycling pathway. Pathogenic variants in genes encoding protein subunits of the TRAPP complex are associated with a range of rare but severe neurological, skeletal, and muscular disorders, collectively called TRAPPopathies. Disease-causing variants have been identified in multiple subunits of the TRAPP complex; however, little is known about the underlying disease mechanisms. In this review, we will provide an overview of the current knowledge surrounding disease-associated variants of the TRAPP complex subunits, propose new insights into the underlying disease pathology, and suggest future research directions into the underlying disease mechanisms.

5 December 2024 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
JPJonathan Payne
Jonathan Payne
KHKristina M. Haebich
Kristina M. Haebich
RMRebecca Mitchell
Rebecca Mitchell
KBKiymet Bozaoglu
Kiymet Bozaoglu
EGEmma Giliberto
Emma Giliberto
DHDarren R. Hocking
Darren R. Hocking